Texto: 
pe:  pelvic mass  (especially on bimanual under anesthesia)	                 
                                    
lab: ua - gross hematuria, malignant cytology
superficial (carcinoma in situ):
endoscopic resection with f/u q3-6 mos
recurrence: laser therapy or intravesical thiotepa, doxorubicin, mitomycin, or bcg.

invasive (extension into muscle or perivesical fat): 
cystectomy
radiation treatment

metastatic (grim prognosis):
chemotherapy: cisplatin, methotrexate, doxorubicin, cyclophosphomide, vinblastine
kub:  punctate, coarse linear calcifications encrusted on surface or within tumor located in the bladder region suggests malignancy.
carcinoma of the bladder
73yo african american male with gross hematuria, otherwise asymptomatic
demographics: men 3x's > women
60-70 years old

associated with the following:
1.) exposure to aromatic amines
(2-naphthylamine)
dye, chemical, rubber industries
2.)  smokers
3.)  recurrent nephrolithiasis
4.)  recurrent uti's
5.)  travel/residence in middle east
chronic schistosomial infections

present with the following symptoms:

1.) gross hematuria (75% of patients) dysuria
2.) frequency
3.) urgency (25% of patients)
4.) pelvic and/or flank pain
5.) visceral or osseous pain from metastasis


Keywords by value: 
- :: 0.05756029155508016 (11095)
- doxorubicin: 0.05718945457732629 (19)
- gross: 0.05653592077226733 (237)
- hematuria: 0.056296451238454746 (175)
- ): 0.05615805910151012 (10569)
- q3-6: 0.04081258529614119 (1)
- thiotepa: 0.04081258529614119 (1)
- cyclophosphomide: 0.04081258529614119 (1)
- 73yo: 0.04081258529614119 (1)
- aromatic: 0.04081258529614119 (1)
- amines: 0.04081258529614119 (9)
- 2-naphthylamine: 0.04081258529614119 (1)
- industries: 0.04081258529614119 (1)
- uti's: 0.04081258529614119 (4)
- travel/residence: 0.04081258529614119 (1)
- schistosomial: 0.04081258529614119 (1)
- intravesical: 0.037603570571326635 (3)
- encrusted: 0.037603570571326635 (2)
- rubber: 0.037603570571326635 (6)
- mitomycin: 0.03572641729304809 (4)
- perivesical: 0.03572641729304809 (3)
- 3x: 0.03572641729304809 (24)
- dye: 0.03572641729304809 (6)
- bcg: 0.03439455584651207 (6)
- grim: 0.03439455584651207 (6)
- east: 0.03439455584651207 (1163)
- recurrent: 0.03338918769560257 (242)
- vinblastine: 0.033361483849687026 (5)
- cisplatin: 0.03251740256823353 (7)
- pelvic: 0.032474543764493456 (382)
- bladder: 0.03211491567823175 (843)
- cystectomy: 0.03180374201347771 (95)
- 60-70: 0.03180374201347771 (8)
- smokers: 0.030640249289954992 (14)
- urgency: 0.028937819752337782 (14)
- mos: 0.028594727288663146 (2141)
- demographics: 0.028594727288663146 (21)
- bimanual: 0.028275315846593922 (16)
- laser: 0.027976526396882945 (20)
- cytology: 0.026717574010384604 (22)
- anesthesia: 0.02629640837054328 (33)
- visceral: 0.02629640837054328 (29)
- kub: 0.025910382403232856 (35)
- situ: 0.02572880502752322 (137)
- dysuria: 0.02572880502752322 (28)
- methotrexate: 0.025223252749907516 (33)
- f/u: 0.024625050289351934 (36)
- chemical: 0.024352640567023538 (82)
- (: 0.023409870757902886 (9594)
- coarse: 0.023399621797559885 (66)
- endoscopic: 0.02329318884281591 (57)
- nephrolithiasis: 0.02329318884281591 (55)
- or: 0.02318339696675249 (60128)
- 5: 0.02314963354114966 (8237)
- punctate: 0.023087393645728718 (50)
- following: 0.022456275526862482 (761)
- carcinoma: 0.022425256203850615 (1515)
- men: 0.022345066562047333 (11914)
- 4: 0.02204603615906523 (7367)
- superficial: 0.021143625842208975 (94)
- ua: 0.02101320511551131 (5833)
- frequency: 0.020886358012788556 (100)
- african: 0.020642637024430123 (122)
- exposure: 0.020583660053238317 (119)
- patients: 0.02047754258672246 (1457)
- 75: 0.02024475540498232 (204)
- invasive: 0.019878378920914156 (165)
- suggests: 0.019778813156002287 (109)
- lab: 0.019355506646929917 (1574)
- women: 0.019222589490066812 (136)
- american: 0.01884530692408911 (182)
- 1: 0.018827095999626915 (15898)
- infections: 0.018805223300278395 (150)
- prognosis: 0.01876548374615158 (166)
- flank: 0.018609851288748872 (162)
- 3: 0.0185275511732087 (8405)
- %: 0.018456676234685256 (2175)
- pe: 0.01777215130345335 (22650)
- surface: 0.017463394940033572 (252)
- under: 0.01728756508787979 (1187)
- recurrence: 0.017258898558954232 (207)
- 2: 0.01703800459731987 (13754)
- osseous: 0.01679691026910066 (295)
- linear: 0.0167711183938717 (281)
- and/or: 0.016719961744859735 (210)
- especially: 0.016283338228789173 (230)
- located: 0.016283338228789173 (256)
- 25: 0.015991788232671632 (658)
- malignancy: 0.015287452212044054 (319)
- ,: 0.015039448084293743 (45533)
- metastasis: 0.014809015399536697 (332)
- calcifications: 0.014709091456633112 (461)
- middle: 0.014468328563159433 (443)
- malignant: 0.0142994012795338 (482)
- muscle: 0.014209792747344189 (802)
- otherwise: 0.014209792747344189 (333)
- chemotherapy: 0.014180304560837338 (419)
- extension: 0.014121885746211357 (611)
- asymptomatic: 0.013373112953685588 (453)
- >: 0.013144294049391502 (1162)
- radiation: 0.012982644673899705 (533)
- resection: 0.012337572479260272 (574)
- fat: 0.012032001494822376 (1111)
- years: 0.011616866375085567 (760)
- region: 0.011174079755737558 (1007)
- chronic: 0.011143470522717592 (888)
- therapy: 0.010577040723336172 (1469)
- metastatic: 0.009958839831555972 (1079)
- symptoms: 0.009859525356009903 (1259)
- pain: 0.009663038588247543 (5051)
- into: 0.009413547999813457 (1299)
- associated: 0.009335474823646767 (1317)
- tumor: 0.009223297692642645 (2333)
- present: 0.00893522571264667 (4525)
- 's: 0.008722438047995579 (1676)
- -: 0.008480224345872053 (21459)
- treatment: 0.00800748592407818 (1790)
- within: 0.007546904668454081 (1927)
- male: 0.007153729342071635 (2906)
- on: 0.006702694558939149 (91641)
- from: 0.0058631283016398715 (3282)
- in: 0.00585273930750354 (113220)
- mass: 0.00550213429142391 (5255)
- old: 0.004050623133621549 (3947)
- the: 0.002560171938956033 (67588)
- with: 0.0021667440016646246 (23954)
- to: 0.001977167168717529 (40381)
- .: 0.001972196449852571 (82185)
- of: 0.0016181083444165058 (41955)
